Population-attributable estimates for risk factors associated with hepatitis B and C: Policy implications for Pakistan and other South Asian countries

Hepatology International

Volumn 7, Issue 2, 2013, Pages 500-507

  Ahmed, Bilal ^a   Ali, Tooba ^b   Qureshi, Huma ^c   Hamid, Saeed ^a  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

^b AGA KHAN UNIVERSITY MEDICAL COLLEGE   (Pakistan)

^c Pakistan Medical and Research Council   (Pakistan)

Author keywords

Hepatitis B; Hepatitis C; Pakistan; Population attributable risk; South Asia

Indexed keywords

ADULT; ARTICLE; ATTRIBUTABLE RISK; CHILD; CONTROLLED STUDY; FEMALE; HEALTH CARE POLICY; HEALTH SURVEY; HEPATITIS B; HEPATITIS C; HIGH RISK POPULATION; HUMAN; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PAKISTAN; PATIENT SAFETY; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SOUTH ASIA; SYSTEMATIC REVIEW; VIRUS TRANSMISSION;

EID: 84879842324     PISSN: 19360533     EISSN: 19360541     Source Type: Journal    
DOI: 10.1007/s12072-012-9417-9     Document Type: Article

References (49)

1. Te HS, Jensen DM. Epidemiology of hepatitis B and C viruses: a global overview. Clin Liver Dis 2010;14(1):1-21
2. Dore GJ, Freeman AJ, Law M, Kaldor JM. Is severe liver disease a common outcome for people with chronic hepatitis C? J Gastroenterol Hepatol 2002;17(4):423-430
3. Perz JF, Armstrong GL, Farrington LA, Hutin YJF, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006;45(4):529-538
4. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004;11(2):97-107
5. Hall A. At last a global response to viral hepatitis. Bull World Health Organ 2010;88:801-802
6. Ali SA, Donahue RMJ, Qureshi H, Vermund SH. Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors. Int J Infect Dis 2009;13(1):9-19
7. Global Burden of Disease Working Group. Global burden of disease (GBD) for hepatitis C. J Clin Pharmacol 2004;44(1):20-29
8. Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. The Lancet 2011;378:571-583
9. Ahmed W, Arif A, Alam SE, Qureshi H. Changing trend of viral hepatitis - "A twenty one year report from Pakistan Medical Research Council Research Centre, Jinnah Postgraduate Medical Centre, Karachi". J Pak Med Assoc 2010;61:86-89
10. Qureshi H, Bile KM, Jooma R, Alam SE, Afridi HUR. Prevalence of hepatitis B and C viral infections in Pakistan: findings of a national survey appealing for effective prevention and control measures. East Mediterr Health J 2010;16:S15-S23
11. Lavanchy D. The global burden of hepatitis C. Liver Int 2009;29:74-81
12. Sievert W, Altraif I, Razavi HA, Abdo A, Ahmed EA, Al Omair A, et al. A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt. Liver Int 2011;31:61-80
13. Janjua NZ, Hamza HB, Islam M, Tirmizi SFA, Siddiqui A, Jafri W, et al. Health care risk factors among women and personal behaviours among men explain the high prevalence of hepatitis C virus infection in Karachi, Pakistan. J Viral Hepat 2010;17(5):317-326
14. Fleiss JL. Inference about population attributable risk from cross-sectional studies. Am J Epidemiol 1979;110(2):103
15. Organization WH. Resolution A63/15: Viral hepatitis. 63rd World Health Assembly. 2010
16. Strathdee SA, Zafar T, Brahmbhatt H, Baksh A. Rise in needle sharing among injection drug users in Pakistan during the Afghanistan war. Drug Alcohol Depend 2003;71(1):17-24.
17. Kuo I. High HCV seroprevalence and HIV drug use risk behaviors among injection drug users in Pakistan. Harm Reduct J 2006;3(1):26
18. Kane A, Lloyd J, Zaffran M, Simonsen L, Kane M. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates. Bull World Health Organ 1999;77(10):801-807
19. Chowdhury AK, Roy T, Faroque AB, Bachar SC, Asaduzzaman M, Nasrin N, et al. A comprehensive situation assessment of injection practices in primary health care hospitals in Bangladesh. BMC Public Health 2011;11(1):779
20. Saravanan S, Velu V, Kumarasamy N, Shankar EM, Nandakumar S, Murugavel KG, et al. The prevalence of hepatitis B virus and hepatitis C virus infection among patients with chronic liver disease in South India. Int J Infect Dis 2008;12(5):513-518
21. Chowdhury A, Santra A, Chaudhuri S, Dhali GK, Chaudhuri S, Maity SG, et al. Hepatitis C virus infection in the general population: a community-based study in West Bengal, India. Hepatology 2003;37(4):802-809
22. Sood A, Vandana M, Neena S, Harpreet K, Malhotra V, Awasthi G. Chronic hepatitis C in northern India. The pathological and clinical spectrum. JAPI 2004;52:380-384
23. Idrees M, Riazuddin S. Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission. BMC Infect Dis 2008;8(1):69
24. Luby SP, Qamruddin K, Shah AA, Omair A, Pahsa O, Khan AJ, et al. The relationship between therapeutic injections and high prevalence of hepatitis C infection in Hafizabad, Pakistan. Epidemiol Infect 1997:349-356
25. Janjua NZ, Akhtar S, Hutin YJF. Injection use in two districts of Pakistan: implications for disease prevention. Int J Qual Health Care 2005;17(5):401
26. Lock G, Dirscherl M, Obermeier F, Gelbmann CM, Hellerbrand C, Knöll A, et al. Hepatitis C - contamination of toothbrushes: myth or reality? J Viral Hepat 2006;13(9):571-573
27. Hayajneh WA, Masaadeh HA, Hayajneh YA. A case-control study of risk factors for hepatitis B virus infection in North Jordan. J Med Virol 2010;82(2):220-223
28. Atmore C, Milne A, Pearce N. Modes of hepatitis B virus transmission in New Zealand. N Z Med J 1989;102(869):277
29. Goh KT, Ding JL, Monteiro EH, Oon CJ. Hepatitis B infection in households of acute cases. J Epidemiol Commun Health 1985;39(2):123
30. Bari A, Akhtar S, Rahbar MH, Luby SP. Risk factors for hepatitis C virus infection in male adults in Rawalpindi-Islamabad, Pakistan. Trop Med Int Health 2001;6(9):732-738
31. Khaliq AA. Barber shaving and blood-borne disease transmission in developing countries. S Afr Med J 2008;95(2):94
32. Janjua NZ, Nizamy MAM. Knowledge and practices of barbers about hepatitis B and C transmission in Rawalpindi and Islamabad. J Pak Med Assoc 2004;54(3):116-118
33. Jafari S, Copes R, Baharlou S, Etminan M, Buxton J. Tattooing and the risk of transmission of hepatitis C: a systematic review and meta-analysis. Int J Infect Dis 2010;14(11):e928-e940
34. Ghias M, Pervaiz MK. Identification of epidemiological risk factors for hepatitis c in Punjab, Pakistan. J Ayub Med Coll Abbottabad 2009;21(2):156-161
35. Usman HR, Akhtar S, Rahbar MH, Hamid S, Moattar T, Luby SP. Injections in health care settings: a risk factor for acute hepatitis B virus infection in Karachi, Pakistan. Population 2003;11:12
36. Masood Z, Jawaid M, Khan RA, Rehman SU. Screening for hepatitis B & C: a routine pre-operative investigation. Pak J Med Sci 2005;21(4):455
37. Chowdhury A, Santra A, Chakravorty R, Banerji A, Pal S, Dhali GK, et al. Community-based epidemiology of hepatitis B virus infection in West Bengal, India: prevalence of hepatitis B e antigen-negative infection and associated viral variants. J Gastroenterol Hepatol 2005;20(11):1712-1720
38. Jagannathan L, Chaturvedi M, Mudaliar S, Kamaladoss T, Rice M, Murphy EL. Risk factors for chronic hepatitis B virus infection among blood donors in Bangalore, India. Transfus Med 2010;20(6):414-420
39. Kumar A, Sharma KA, Gupta RK, Kar P, Chakravarti A. Prevalence & risk factors for hepatitis C virus among pregnant women. Indian J Med Res 2007;126(3):211
40. Thakral B, Marwaha N, Chawla YK, Saluja K, Sharma A, Sharma RR, et al. Prevalence & significance of hepatitis C virus (HCV) seropositivity in blood donors. Indian J Med Res 2006;124(4):431
41. Ashraf H, Alam N, Rothermundt C, Brooks A, Bardhan P, Hossain L, et al. Prevalence and risk factors of hepatitis B and C virus infections in an impoverished urban community in Dhaka, Bangladesh. BMC Infect Dis 2010;10(1):208
42. Gibney L, Saquib N, Metzger J, Choudhury P, Siddiqui MA, Hassan MS. Human immunodeficiency virus, hepatitis B, C and D in Bangladesh's trucking industry: prevalence and risk factors. Int J Epidemiol 2001;30(4):878-884
43. Mahtab M, Rahman S, Karim MF, Khan M, Foster G, Solaiman S, et al. Epidemiology of hepatitis B virus in Bangladeshi general population. Hepatobiliary Pancreat Dis Int 2008;7(6):595-600
44. Shirin T, Ahmed T, Iqbal A, Islam M, Islam MN. Prevalence and risk factors of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infections among drug addicts in Bangladesh. J Health Popul Nutr 2011;18(3):145-150
45. Hajiani E, Hashemi J, Masjedizadeh R, Shayesteh AA, Idani E, Rajabi T. Seroepidemiology of hepatitis C and its risk factors in Khuzestan Province, south-west of Iran: a case-control study. World Journal Gastroenterol 2006;12(30):4884
46. Jahani MR, Motevalian SA, Mahmoodi M. Hepatitis B carriers in large vehicle drivers of Iran. Vaccine 2003;21(17-18):1948-1951
47. Merat S, Rezvan H, Nouraie M, Jamali A, Assari S, Abolghasemi H, et al. The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population-based study. Arch Iran Med 2009;12(3):225-231
48. Zamani S, Ichikawa S, Nassirimanesh B, Vazirian M, Ichikawa K, Gouya MM, et al. Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran. Int J Drug Policy 2007;18(5):359-363
49. Shahnaz Sali MD, Reza Bashtar MD, Seyed-Moayed Alavian MD. Risk factors in chronic hepatitis B infection: a case-control study. Hepat Mon 2005;5(4):109-115